MVP Contest News Alert:  NEIK Northstar Electronics CEO

New Post Public Reply Private Reply Replies (0) Message Board
RobInvest

MVP Contest News Alert:  NEIK

Northstar Electronics CEO Executes Stock Conversion
VANCOUVER, BC, Jun 07, 2012 (MARKETWIRE via COMTEX) -- Northstar Electronics, Inc. (OTCQB: NEIK) (PINKSHEETS: NEIK) announces today the conversion to common stock of funds owed to Dr. Wilson Russell, CEO of Northstar Electronics.

On May 22, 2012, Dr. Wilson Russell, CEO and Director of Northstar Electronics converted two hundred thousand US dollars ($200,000) of monies owed to him by the company into common shares of company stock. The price of conversion was five cents per share ($0.05).

This brings total conversions by Dr. Russell cumulatively to approximately four hundred and fifty thousand dollars ($450,000) into common stock over the last few years, all executed at share prices higher than trading prices at the times of conversion.

Northstar Electronics now trades on the OTCQB and intends to maintain its reporting status with the SEC.

About Northstar Electronics, Inc.

Northstar Electronics, Inc. is a holding company with executive management specialized in design engineering, defense, advanced systems, security, sonar, systems integration, and prototyping fields. Echotec Sonar Corporation is a wholly owned subsidiary with founders that have over eighty combined man-years of expertise developing high-frequency sonar products within the defense and commercial industries. Northstar is actively pursuing opportunities through acquisition, joint venture, or merger to increase revenues and expand its base of subsidiaries.  http://www.northstarelectronics.com

Safe Harbor Statement This press release contains forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as its future results of operations and financial condition. Such risks include, but are not limited to, the effects of competition with existing enterprises and/or new entrants into the company's markets and industries, fluctuations in currency exchange rates, domestic and global economic conditions generally, the company's ability to obtain financing and attract suitable personnel where required to fully implement its business plan, the adoption and acceptance by the marketplace of the company's technologies and product and service offerings, the possibility of new technologies that are competitive with the company's planned product and service offerings and the effects of future political and economic developments both in the United States and abroad, among others. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of information, future events or otherwise.

 

 

 For further information contact 
Rich Kaiser
Investor Relations
YES INTERNATIONAL
yes@yesinternational.com
800-631-8127 


 
SOURCE: Northstar Electronics, Inc.

 

 

 

 CONTACT:          mailto:yes@yesinternational.com

 
 Copyright 2012  Marketwire, Inc., All rights reserved.
 
-0-

 

 SUBJECT CODE:     Aerospace and Defense:Electronics and Communications
                  Aerospace and Defense:Marinecraft
                  Computers and Software:Hardware
                  Computers and Software:Internet
                  Transportation and Logistics:Maritime
                  Computers and Software eripherals
                  Computers and Software:Software
                  Government:Security (law enforcement, homeland etc)
                  Computers and Software:Networking 

87113432_827586823_ihmvp-contest-were-back.png
Quick Links: MVP Board - OTC Stock Contest - Big Board Stock Contest - Portfolio Challenge - Blog - iStockify
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ovation's Roadmap for Revitalizing Rural Healthcare

Updated Category News Views 5

Steering Rural Healthcare Towards a Brighter Future Alright, here we are with Ovation Healthcare trying to inject some much-needed life into the sometimes forgotten corners of the healthcare world—those rural hospitals. They’ve cooked up a fresh white paper, and it’s got the makings of a lifeline for these institutions swirling in red ink. The financial landscape...

Continue Reading
ProperHeir Expands with New Innovative Office Space

Updated Category News Views 194

ProperHeir Expands with New Innovative Office Space ProperHeir has recently announced an exciting development with the opening of its new office at the Miramar Tech Center. This expansion marks a significant milestone as the company has tripled its available space. The chief purpose of this new office is to effectively host its growing in-house sales team and provide a...

Continue Reading
Discover How Octa Transforms Forex Trading for Singaporeans

Updated Category News Views 95

Understanding the Forex Market The foreign exchange market, commonly known as forex, stands as the largest and most dynamic financial market in the world. It allows traders to buy and sell currencies, leveraging the fluctuations in exchange rates to boost their earnings. Operating continuously from Monday to Friday, this market presents individual traders with the chance...

Continue Reading
Seoul Business Agency Powers Startups at the CES 2026 Pavilion

Updated Category News Views 176

Seoul Business Agency Showcases Startups at CES 2026 Pavilion The Seoul Business Agency (SBA) has taken ambitious strides to support the innovative spirit of Seoul's startups at CES 2026. Engaging with 19 prestigious institutions within Seoul’s ecosystem, the SBA is dedicated to empowering 70 startups as they venture onto the global stage. The 'Seoul POP' themed...

Continue Reading
VYJUVEK® Receives Groundbreaking Approval for DEB Treatment

Updated Category News Views 252

VYJUVEK® Approved for Dystrophic Epidermolysis Bullosa Treatment VYJUVEK approved for DEB treatment from birth, offering flexible home administration options for patients and their families. This breakthrough marks VYJUVEK as the first genetic medicine approved in Japan for DEB. Recently, Krystal Biotech, Inc. (NASDAQ: KRYS) announced that its innovative treatment,...

Continue Reading